The Effect of the COVID-19 Pandemic on the Medical Mode of Patients With Inflammatory Bowel Disease in China

Inflamm Bowel Dis. 2020 Sep 18;26(10):e116-e117. doi: 10.1093/ibd/izaa197.

Authors

Wen-Ning Tian¹, Yu-Hong Huang¹, Cong Dai¹

Affiliation

¹ Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.

No abstract available

Keywords: COVID-19; inflammatory bowel disease; medical mode.

Publication types

Letter

MeSH terms

Adult
Anti-Inflammatory Agents / classification
Anti-Inflammatory Agents / therapeutic use*
Betacoronavirus
COVID-19
China / epidemiology
Coronavirus Infections* / epidemiology
Coronavirus Infections* / prevention & control
Coronavirus Infections* / transmission
Critical Pathways* / organization & administration
Critical Pathways* / trends
Disease Transmission, Infectious / prevention & control
Female
Humans
Infection Control
Inflammatory Bowel Diseases / diagnosis
Inflammatory Bowel Diseases / therapy
Male
Middle Aged
Organizational Innovation
Pandemics / prevention & control*
Patient Care Management* / methods
Patient Care Management* / trends
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / prevention & control
Pneumonia, Viral* / transmission
SARS-CoV-2

Substances

Anti-Inflammatory Agents